Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ELITE PHARMACEUTICALS INC /NV/ELTP · Entity 5936 | Director | February 26, 2018 | February 27, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ELITE PHARMACEUTICALS INC /NV/
Report date February 26, 2018 · Filed February 27, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 233,414 |
Reported balance
After 2018-02-26 transaction · row 1
1 source rowRow 1 · 2018-02-26 · Grant · Acquired 161,374 · Balance 233,414 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2018 Filed Feb 27, 2018 22:15 UTC | ELITE PHARMACEUTICALS INC /NV/ ELTP · Entity 5936 | GrantCommon Stock | 161,374 | $0.12 | $19,994.24 |
DisclosureSEC source: 0001053369-18-000006 · primary_doc.xml · nonDerivative · entry 1 Pfeifer Eugene M · CIK 0001672351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233,414 Read SEC document |
| February 23, 2017 Filed Feb 28, 2017 00:08 UTC | ELITE PHARMACEUTICALS INC /NV/ ELTP · Entity 5936 | GrantCommon Stock | 72,040 | $0.20 | $14,588.10 |
DisclosureSEC source: 0001053369-17-000007 · primary_doc.xml · nonDerivative · entry 1 Pfeifer Eugene M · CIK 0001672351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,040 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.